L-type Ca2+ channels' involvement in IFN-γ-induced signaling in rat ventricular cardiomyocytes

J Physiol Biochem. 2019 Feb;75(1):109-115. doi: 10.1007/s13105-019-00662-y. Epub 2019 Feb 12.

Abstract

The purpose of this study was to examine the effects of interferon-γ (IFN-γ) on calcium movement in rat ventricular myocytes. L-type Ca2+ currents (ICa,L) were recorded with the whole-cell configuration of the patch-clamp techniques. IFN-γ induces current density reduction at the test potential of 0 mV by 47.6 ± 7.4%. Heparin, a selective inhibitor of inositol-1,4,5-triphosphate (IP3)-induced Ca2+ release, applied via a patch pipette, induced an ICa,L amplitude decrease of about 46 ± 5.6%. The addition of IFN-γ to heparin-treated cells has no effect on ICa,L. Ryanodine induced an ICa,L current amplitude decrease of 35.1 ± 6.2%. The addition of IFN-γ to ryanodine-treated cells caused an additional ICa,L inhibiting of 17.6 ± 4.8%. Both cyclopiazonic acid (CPA), a specific SERCA inhibitor, and a combination of CPA and ryanodine caused a significant reduction of the ICa,L amplitudes. Subsequent addition of IFN-γ inhibited ICa,L for an additional 16.3 ± 4.4%. The employment of chelerythrine in this study prevented IFN-γ-induced L-type Ca2+ channel inhibition in only 10 min from the start of perfusion. Proposed mechanisms of regulation involved IFN-γ-induced IP3-sensitive Ca2+ release probably by a Ca2+-dependent translocation of PKC from the cytoplasm to the cell membrane as the obligatory first step of the IFN-γ-induced PKC-dependent L-type Ca2+ channel inhibition.

Keywords: Cytokine; Interferon-γ; L-type Ca 2+ channels; Rat; Store-operated Ca2+ entry; Ventricular cardiomyocytes.

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology
  • Animals
  • Benzophenanthridines / pharmacology
  • Calcium / metabolism*
  • Calcium Channels, L-Type / metabolism*
  • Heart Ventricles / cytology
  • Heart Ventricles / drug effects
  • Heart Ventricles / metabolism
  • Heparin / pharmacology
  • Indoles / pharmacology
  • Inositol 1,4,5-Trisphosphate / metabolism
  • Interferon-gamma / pharmacology*
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / metabolism
  • Patch-Clamp Techniques
  • Primary Cell Culture
  • Protein Kinase C / metabolism
  • Protein Transport
  • Rats
  • Rats, Wistar
  • Ryanodine / pharmacology
  • Sarcoplasmic Reticulum / drug effects
  • Sarcoplasmic Reticulum / metabolism
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism*
  • Signal Transduction / drug effects*

Substances

  • Benzophenanthridines
  • Calcium Channels, L-Type
  • Indoles
  • Ryanodine
  • Interferon-gamma
  • Inositol 1,4,5-Trisphosphate
  • Heparin
  • chelerythrine
  • Protein Kinase C
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Calcium
  • cyclopiazonic acid